| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | MILLIKELVIN TECHNOLOGIES LLC | 50 BRAINTREE HILL PARK STE 301 | BRAINTREE | MA | 02184-8811 | NORFOLK | USA | R43EB025685 | Driven Feedback Enhanced Magnetic Resonance Spectroscopic Quantification of Non-Radioactive 19 FDG in Tumors | 000 | 1 | NIH | 9/28/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2020 | MILLIKELVIN TECHNOLOGIES LLC | 50 BRAINTREE HILL PARK STE 301 | BRAINTREE | MA | 02184-8811 | NORFOLK | USA | R43EB025685 | Driven Feedback Enhanced Magnetic Resonance Spectroscopic Quantification of Non-Radioactive 19 FDG in Tumors | 000 | 1 | NIH | 5/4/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2020 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43EB025685 | Driven Feedback Enhanced Magnetic Resonance Spectroscopic Quantification of Non-Radioactive 19 FDG in Tumors | 000 | 1 | NIH | 11/26/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $299,173 ) |
| | 2020 | 2020 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43EB025685 | Driven Feedback Enhanced Magnetic Resonance Spectroscopic Quantification of Non-Radioactive 19 FDG in Tumors | 000 | 1 | NIH | 9/21/2020 | $299,173 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43AG057283 | Improved Imaging of an MR Molecular Agent Using Driven Feedback Contrast Enhancement | 000 | 1 | NIH | 9/23/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = -$4 ) |
| | 2018 | 2014 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43EB019829 | Enabling Metabolic Imaging Using Feedback Driven Magnetic Resonance Spectroscopy | 000 | 1 | NIH | 12/30/2017 | -$4 |
|
| Issue Date FY: 2017 ( Subtotal = $221,134 ) |
| | 2017 | 2017 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43AG057283 | Improved Imaging of an MR Molecular Agent Using Driven Feedback Contrast Enhancement | 000 | 1 | NIH | 7/14/2017 | $221,134 |
| | 2017 | 2014 | MILLIKELVIN TECHNOLOGY LLC | 3 GERRY ST | MARBLEHEAD | MA | 01945-3029 | ESSEX | USA | R43EB019829 | Enabling Metabolic Imaging Using Feedback Driven Magnetic Resonance Spectroscopy | 000 | 1 | NIH | 12/7/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2014 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43EB019829 | Enabling Metabolic Imaging Using Feedback Driven Magnetic Resonance Spectroscopy | 000 | 1 | NIH | 9/8/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $213,347 ) |
| | 2014 | 2014 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43EB019829 | Enabling Metabolic Imaging Using Feedback Driven Magnetic Resonance Spectroscopy | 000 | 1 | NIH | 9/25/2014 | $213,347 |
|
| Issue Date FY: 2011 ( Subtotal = $0 ) |
| | 2011 | 2009 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43RR026164 | MANUFACTURE AND SUPPLY OF HYPERPOLARIZED CHLOROFORM FOR USE AS AN NMR SOLVENT | 000 | 1 | NIH | 11/5/2010 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $0 ) |
| | 2010 | 2009 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43HL095235 | ENABLING METABOLIC IMAGING USING HYPERPOLARIZED 13C MAGNETIC RESONANCE | 000 | 1 | NIH | 4/23/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $370,248 ) |
| | 2009 | 2009 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43HL095235 | ENABLING METABOLIC IMAGING USING HYPERPOLARIZED 13C MAGNETIC RESONANCE | 000 | 1 | NIH | 3/27/2009 | $196,960 |
| | 2009 | 2009 | MILLIKELVIN TECHNOLOGIES LLC | 3 GERRY STREET | MARBLEHEAD | MA | 01945 | ESSEX | USA | R43RR026164 | MANUFACTURE AND SUPPLY OF HYPERPOLARIZED CHLOROFORM FOR USE AS AN NMR SOLVENT | 000 | 1 | NIH | 8/27/2009 | $173,288 |
|
|
